These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1864255)

  • 1. [Treatment of resistant depression with the citalopram-lithium combination. Methodology of a double-blind multicenter study and preliminary results].
    Souche A; Montaldi S; Uehlinger C; Kasas A; Reymond MJ; Reymond P; Baumann P; Dufour H
    Encephale; 1991; 17(3):213-9. PubMed ID: 1864255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation.
    Baumann P; Nil R; Souche A; Montaldi S; Baettig D; Lambert S; Uehlinger C; Kasas A; Amey M; Jonzier-Perey M
    J Clin Psychopharmacol; 1996 Aug; 16(4):307-14. PubMed ID: 8835706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders].
    Lôo H; Daléry J; Macher JP; Payen A
    Encephale; 2002; 28(4):356-62. PubMed ID: 12232545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders].
    Lôo H; Daléry J; Macher JP; Payen A
    Encephale; 2003; 29(2):165-71. PubMed ID: 14567168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression.
    Shapira B; Yagmur MJ; Gropp C; Newman M; Lerer B
    Biol Psychiatry; 1992 May; 31(10):975-83. PubMed ID: 1511080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings: analysis of Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) data.
    Bobo WV; Angleró GC; Jenkins G; Hall-Flavin DK; Weinshilboum R; Biernacka JM
    Hum Psychopharmacol; 2016 May; 31(3):185-92. PubMed ID: 26999588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia.
    Mendels J; Kiev A; Fabre LF
    Depress Anxiety; 1999; 9(2):54-60. PubMed ID: 10207659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression.
    Januel D; Poirier MF; D'alche-Biree F; Dib M; Olié JP
    J Affect Disord; 2003 Sep; 76(1-3):191-200. PubMed ID: 12943949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Concentrations and Cardiovascular Effects of Citalopram Enantiomers After Oral Versus Infusion Citalopram Therapy in Dextromethorphan-Mephenytoin-Phenotyped Patients With Major Depression.
    Baumann P; Bertschy G; Ramseier F; Nil R
    Ther Drug Monit; 2021 Jun; 43(3):436-442. PubMed ID: 33060488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using non-steroidal anti-inflammatory drugs in the treatment of depression.
    Davis A; Gilhooley M; Agius M
    Psychiatr Danub; 2010 Nov; 22 Suppl 1():S49-52. PubMed ID: 21057403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
    Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan PT; Kane CP
    CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study.
    Bloch M; Schwartzman Y; Bonne O; Lerer B
    J Clin Psychopharmacol; 1997 Feb; 17(1):44-8. PubMed ID: 9004056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram.
    Andersen G; Vestergaard K; Lauritzen L
    Stroke; 1994 Jun; 25(6):1099-104. PubMed ID: 8202964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenfluramine challenge test in obsessive-compulsive disorder--first results.
    Pidrman V; Tůma I
    Acta Medica (Hradec Kralove); 1997; 40(4):99-102. PubMed ID: 9481883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.
    Nowak G; Siwek M; Dudek D; Zieba A; Pilc A
    Pol J Pharmacol; 2003; 55(6):1143-7. PubMed ID: 14730113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.